BIOCRYST PHARMACEUTICALS INC Logo

BIOCRYST PHARMACEUTICALS INC

Develops novel medicines for patients with rare and serious diseases.

BCRX | US

Overview

Corporate Details

ISIN(s):
US09058V1035
LEI:
Country:
United States of America
Address:
4505 EMPEROR BOULEVARD, 27703 DURHAM

Description

BioCryst Pharmaceuticals Inc. is a commercial-stage biotechnology company dedicated to discovering, developing, and commercializing novel medicines for patients with rare and serious diseases. The company's primary focus is on hereditary angioedema (HAE), alongside other rare conditions. BioCryst utilizes its expertise in structure-guided drug design, a process that integrates advanced technologies with biology and medicinal chemistry, to create innovative therapies. It specializes in developing first-in-class or best-in-class oral small-molecule and protein therapeutics, aiming to provide more convenient and effective treatment options for patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-11 08:25
FORM 8-K
English 64.0 KB
2025-12-03 19:40
PRIMARY DOCUMENT
English 8.0 KB
2025-12-03 15:01 English 7.5 KB
2025-12-03 09:00
8-K
English 731.8 KB
2025-12-02 17:14
PRIMARY DOCUMENT
English 6.5 KB
2025-12-02 17:10
PRIMARY DOCUMENT
English 6.6 KB
2025-12-02 17:07
PRIMARY DOCUMENT
English 6.7 KB
2025-12-02 15:09 English 7.5 KB
2025-12-01 13:51 English 6.9 KB
2025-11-25 17:31 English 7.2 KB
2025-11-21 17:29 English 7.0 KB
2025-11-20 18:17
S-4
English 1.0 MB
2025-11-17 17:07
PRIMARY DOCUMENT
English 6.8 KB
2025-11-13 11:21 English 7.1 KB
2025-11-12 21:27 English 12.7 KB

Automate Your Workflow. Get a real-time feed of all BIOCRYST PHARMACEUTICALS INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for BIOCRYST PHARMACEUTICALS INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for BIOCRYST PHARMACEUTICALS INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Acurx Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing a new class of antibiotics for priority pathogens.
United States of America
ACXP
Adaptimmune Therapeutics PLC Logo
Commercial-stage biopharma developing TCR T-cell therapies for solid tumors.
United States of America
ADAP
ADBIOTECH Co.,Ltd. Logo
Develops IgY-based immune antibodies as alternatives to vaccines and antibiotics.
South Korea
179530
ADC Therapeutics SA Logo
Commercial-stage biotech developing antibody-drug conjugates for cancer therapy.
United States of America
ADCT
Addex Therapeutics Ltd. Logo
Clinical-stage biopharma developing allosteric modulators for neurological disorders.
Switzerland
ADXN
ADIAL PHARMACEUTICALS, INC. Logo
A clinical-stage biopharma developing genetically targeted therapies for addiction.
United States of America
ADIL
Adicet Bio, Inc. Logo
Develops allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.
United States of America
ACET
Adlai Nortye Ltd. Logo
A clinical-stage biopharma firm developing cancer immunotherapies and RAS-targeting drugs.
United States of America
ANL
ADMA BIOLOGICS, INC. Logo
Biopharmaceutical company that develops and manufactures plasma-derived biologics.
United States of America
ADMA
Adverum Biotechnologies, Inc. Logo
A clinical-stage company developing gene therapies for ocular diseases.
United States of America
ADVM

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.